Vanderbilt Ingram Cancer Center

Mia Levy, M.D., Ph.D., Ingram Assistant Professor of Cancer Research and director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center (VICC), has been named director of Cancer Health Information and Strategy, a new management post that will expand her leadership role.

Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has received a 2015 Cancer Clinical Investigator Team Leadership Award (CCITLA) from the National Cancer Institute (NCI).

Vanderbilt University may nominate five candidates for the 2016 Damon Runyon Cancer Research Foundation Clinical Investigator Award.

In 2005, Tennessee philanthropists Jim and Janet Ayers gave $10 million to help Vanderbilt University scientists find early markers for colorectal cancer that could improve diagnosis and potentially save lives.

Cancer survivors, family and friends rock to tunes performed by Soul Incision during the annual cancer Survivors Day celebration.

Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.

Vanderbilt University Medical Center investigators have joined forces with scientists at Incyte Corp. to explore new therapies for the treatment of various types of cancer, as well as other diseases. The company has agreed to help fund basic and translational science research by VUMC investigators.